Alejandro López-Soto

University of Oviedo

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Miguel A. Jimenez-Clavero

Profesor de Investigación

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria

SPAIN

View details

Jose M.P. Freije

Professor

University of Oviedo

SPAIN

View details

Alicia R. Folgueras

SPAIN

View details

David Rodríguez

Profesor Ayudante Doctor

University of Oviedo

SPAIN

View details

Christian Sordo Bahamonde

SPAIN

View details

Víctor Quesada

University of Oviedo

SPAIN

View details

Alejandra Martínez-Pérez

University of Oviedo

SPAIN

View details

GUILLERMO MARIÑO GARCÍA

Professor

University of Oviedo

SPAIN

View details

CARLES BARCELÓ, PhD

Associate Professor / Master thesis director

Open University of Catalonia

SPAIN

View details

Segundo Gonzalez

University of Oviedo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alejandro López-Soto

Research Interests

Explore related searches

Contact this professor

Articles (11)

Correction to: The effect of physical exercise on anticancer immunity (Nature Reviews Immunology, (2023), 10.1038/s41577-023-00943-0)

The effect of physical exercise on anticancer immunity

The secretome atlas of two mouse models of progeria

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.

Autophagy‐linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS‐CoV‐2 entry into human cells

BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia

LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia

Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer

Mechanisms of Resistance to NK Cell Immunotherapy

Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors

Collaborators (10)

Miguel A. Jimenez-Clavero

Jose M.P. Freije

Alicia R. Folgueras

David Rodríguez

Christian Sordo Bahamonde

Víctor Quesada

Alejandra Martínez-Pérez

GUILLERMO MARIÑO GARCÍA

CARLES BARCELÓ, PhD

Segundo Gonzalez

Make your next move.